"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable
- PMID: 14525889
- PMCID: PMC214164
- DOI: 10.1136/bmj.327.7418.808-c
"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable
Figures
Comment on
-
A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries.BMJ. 2003 Jun 28;326(7404):1407-8. doi: 10.1136/bmj.326.7404.1407. BMJ. 2003. PMID: 12829526 Free PMC article. No abstract available.
-
A strategy to reduce cardiovascular disease by more than 80%.BMJ. 2003 Jun 28;326(7404):1419. doi: 10.1136/bmj.326.7404.1419. BMJ. 2003. PMID: 12829553 Free PMC article.
References
-
- Messori A, Santarlasci B, Trippoli S, Vaiani M. Questionable cost-effectiveness of statins for primary prevention of cardiovascular events [electronic response to Wald et al]. bmj.com 2003. bmj.com/cgi/eletters/326/7404/1407#34612; correction bmj.com/cgi/eletters/326/7404/1407#34905 (accessed 31 Aug 2003). - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical